There are also reports of progressive renal failure in MLIV patients, and blockade of TRPML1 was found to suppress the interaction of lysosomes and multivesicular bodies, leading to increased exosome release from mouse podocytes.1146. Here, MCOLN1 is linked to mucolipidosis type IV.